-
Je něco špatně v tomto záznamu ?
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
L. Prochazkova, DP. Lippelt, LS. Colzato, M. Kuchar, Z. Sjoerds, B. Hommel,
Jazyk angličtina Země Německo
Typ dokumentu klinické zkoušky, fáze I, časopisecké články, pragmatická klinická studie
NLK
ProQuest Central
od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1996-10-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-02-01 do Před 1 rokem
Psychology Database (ProQuest)
od 1997-02-01 do Před 1 rokem
- MeSH
- dospělí MeSH
- halucinogeny aplikace a dávkování MeSH
- inteligence účinky léků fyziologie MeSH
- inteligenční testy MeSH
- klinické zkoušky, fáze I jako téma MeSH
- kreativita * MeSH
- lidé MeSH
- mladý dospělý MeSH
- motivace účinky léků fyziologie MeSH
- myšlení účinky léků fyziologie MeSH
- nootropní látky aplikace a dávkování MeSH
- řešení problému účinky léků fyziologie MeSH
- světelná stimulace metody MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky, fáze I MeSH
- pragmatická klinická studie MeSH
INTRODUCTION: Taking microdoses (a mere fraction of normal doses) of psychedelic substances, such as truffles, recently gained popularity, as it allegedly has multiple beneficial effects including creativity and problem-solving performance, potentially through targeting serotonergic 5-HT2A receptors and promoting cognitive flexibility, crucial to creative thinking. Nevertheless, enhancing effects of microdosing remain anecdotal, and in the absence of quantitative research on microdosing psychedelics, it is impossible to draw definitive conclusions on that matter. Here, our main aim was to quantitatively explore the cognitive-enhancing potential of microdosing psychedelics in healthy adults. METHODS: During a microdosing event organized by the Dutch Psychedelic Society, we examined the effects of psychedelic truffles (which were later analyzed to quantify active psychedelic alkaloids) on two creativity-related problem-solving tasks: the Picture Concept Task assessing convergent thinking and the Alternative Uses Task assessing divergent thinking. A short version of the Ravens Progressive Matrices task assessed potential changes in fluid intelligence. We tested once before taking a microdose and once while the effects were expected to be manifested. RESULTS: We found that both convergent and divergent thinking performance was improved after a non-blinded microdose, whereas fluid intelligence was unaffected. CONCLUSION: While this study provides quantitative support for the cognitive-enhancing properties of microdosing psychedelics, future research has to confirm these preliminary findings in more rigorous placebo-controlled study designs. Based on these preliminary results, we speculate that psychedelics might affect cognitive metacontrol policies by optimizing the balance between cognitive persistence and flexibility. We hope this study will motivate future microdosing studies with more controlled designs to test this hypothesis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012227
- 003
- CZ-PrNML
- 005
- 20190416110504.0
- 007
- ta
- 008
- 190405s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00213-018-5049-7 $2 doi
- 035 __
- $a (PubMed)30357434
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Prochazkova, Luisa $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands. l.prochazkova@fsw.leidenuniv.nl.
- 245 10
- $a Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting / $c L. Prochazkova, DP. Lippelt, LS. Colzato, M. Kuchar, Z. Sjoerds, B. Hommel,
- 520 9_
- $a INTRODUCTION: Taking microdoses (a mere fraction of normal doses) of psychedelic substances, such as truffles, recently gained popularity, as it allegedly has multiple beneficial effects including creativity and problem-solving performance, potentially through targeting serotonergic 5-HT2A receptors and promoting cognitive flexibility, crucial to creative thinking. Nevertheless, enhancing effects of microdosing remain anecdotal, and in the absence of quantitative research on microdosing psychedelics, it is impossible to draw definitive conclusions on that matter. Here, our main aim was to quantitatively explore the cognitive-enhancing potential of microdosing psychedelics in healthy adults. METHODS: During a microdosing event organized by the Dutch Psychedelic Society, we examined the effects of psychedelic truffles (which were later analyzed to quantify active psychedelic alkaloids) on two creativity-related problem-solving tasks: the Picture Concept Task assessing convergent thinking and the Alternative Uses Task assessing divergent thinking. A short version of the Ravens Progressive Matrices task assessed potential changes in fluid intelligence. We tested once before taking a microdose and once while the effects were expected to be manifested. RESULTS: We found that both convergent and divergent thinking performance was improved after a non-blinded microdose, whereas fluid intelligence was unaffected. CONCLUSION: While this study provides quantitative support for the cognitive-enhancing properties of microdosing psychedelics, future research has to confirm these preliminary findings in more rigorous placebo-controlled study designs. Based on these preliminary results, we speculate that psychedelics might affect cognitive metacontrol policies by optimizing the balance between cognitive persistence and flexibility. We hope this study will motivate future microdosing studies with more controlled designs to test this hypothesis.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a klinické zkoušky, fáze I jako téma $7 D017321
- 650 12
- $a kreativita $7 D003405
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a halucinogeny $x aplikace a dávkování $7 D006213
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inteligence $x účinky léků $x fyziologie $7 D007360
- 650 _2
- $a inteligenční testy $7 D007361
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a motivace $x účinky léků $x fyziologie $7 D009042
- 650 _2
- $a nootropní látky $x aplikace a dávkování $7 D018697
- 650 _2
- $a světelná stimulace $x metody $7 D010775
- 650 _2
- $a řešení problému $x účinky léků $x fyziologie $7 D011340
- 650 _2
- $a myšlení $x účinky léků $x fyziologie $7 D013850
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a klinické zkoušky, fáze I $7 D017426
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pragmatická klinická studie $7 D065007
- 700 1_
- $a Lippelt, Dominique P $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
- 700 1_
- $a Colzato, Lorenza S $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands. Department of Cognitive Psychology, Institute of Cognitive Neuroscience, Faculty of Psychology, Ruhr University Bochum, Bochum, Germany. Institute for Sports and Sport Science, University of Kassel, Kassel, Germany.
- 700 1_
- $a Kuchar, Martin $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czech Republic. Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.
- 700 1_
- $a Sjoerds, Zsuzsika $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
- 700 1_
- $a Hommel, Bernhard $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
- 773 0_
- $w MED00003990 $t Psychopharmacology $x 1432-2072 $g Roč. 235, č. 12 (2018), s. 3401-3413
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30357434 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190416110529 $b ABA008
- 999 __
- $a ok $b bmc $g 1391537 $s 1050532
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 235 $c 12 $d 3401-3413 $e 20181025 $i 1432-2072 $m Psychopharmacology $n Psychopharmacology $x MED00003990
- LZP __
- $a Pubmed-20190405